Effects of Almonds in Glucose-intolerant Adults (AGAMEMNON)

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 23, 2024

Primary Completion Date

April 1, 2026

Study Completion Date

July 1, 2026

Conditions
PreDiabetesNAFLD
Interventions
DIETARY_SUPPLEMENT

Raw whole almonds

Subjects will be supplemented with 60 grams of almonds (treatment) or left untreated (no-nut group) for 16 weeks. Patients of the no-nut group will receive 6,7 kgs of almonds after finishing the study, supporting their compliance as untreated group.

Trial Locations (1)

12203

RECRUITING

Charite University Hospital Berlin, Berlin

All Listed Sponsors
collaborator

Almond Board of California

OTHER

lead

Charite University, Berlin, Germany

OTHER